• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives Chlorinated biphenyls

Recent Advances in the Study of 5-(3,5-dichlorophenyl)-2-hydroxybenzaldehyde (CAS: 1111120-99-0) in Chemical Biology and Pharmaceutical Research

5-(3,5-dichlorophenyl)-2-hydroxybenzaldehyde (CAS: 1111120-99-0) is a synthetic organic compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its dichlorophenyl and hydroxybenzaldehyde moieties, exhibits unique chemical properties that make it a promising candidate for drug discovery and development. Recent studies have explored its role as a key intermediate in the synthesis of bioactive molecules, as well as its direct biological activities.

One of the most notable findings in recent research is the compound's potential as an inhibitor of specific enzymatic pathways. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 5-(3,5-dichlorophenyl)-2-hydroxybenzaldehyde exhibits inhibitory activity against certain kinases involved in inflammatory responses. The study utilized molecular docking simulations and in vitro assays to elucidate the compound's binding affinity and mechanism of action, providing valuable insights for the development of novel anti-inflammatory agents.

In addition to its enzymatic inhibition properties, recent investigations have highlighted the compound's role in antimicrobial applications. Research conducted at several academic institutions has shown that derivatives of 5-(3,5-dichlorophenyl)-2-hydroxybenzaldehyde display significant activity against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). These findings, published in Bioorganic & Medicinal Chemistry Letters, suggest that structural modifications of this compound could lead to the development of new classes of antibiotics to address the growing challenge of antimicrobial resistance.

The synthetic versatility of 5-(3,5-dichlorophenyl)-2-hydroxybenzaldehyde has also been a focus of recent research. A 2024 study in Organic & Biomolecular Chemistry detailed novel synthetic routes for this compound, improving yield and purity while reducing environmental impact through greener chemistry approaches. These methodological advancements are particularly significant for scaling up production for potential pharmaceutical applications.

From a structural perspective, computational studies have provided deeper understanding of the compound's conformation and electronic properties. Quantum chemical calculations and molecular dynamics simulations have revealed how the dichlorophenyl and hydroxybenzaldehyde groups interact to influence the compound's reactivity and biological activity. These theoretical insights, combined with experimental data, are guiding the rational design of more potent derivatives.

Looking forward, researchers are particularly interested in exploring the compound's potential in targeted drug delivery systems. Preliminary studies suggest that 5-(3,5-dichlorophenyl)-2-hydroxybenzaldehyde could serve as a scaffold for developing prodrugs or as a targeting moiety due to its specific molecular interactions. Several pharmaceutical companies have included this compound in their screening libraries for new drug discovery programs.

While the research on 5-(3,5-dichlorophenyl)-2-hydroxybenzaldehyde shows great promise, challenges remain in translating these findings into clinical applications. Future studies will need to address pharmacokinetic properties, toxicity profiles, and formulation stability to fully realize the therapeutic potential of this compound and its derivatives. Nevertheless, the current body of research positions this molecule as an important subject of study in chemical biology and pharmaceutical sciences.

• 32596-43-3(5-Chloro-2-hydroxyisophthalaldehyde)
• 1262003-94-0(5-(3,5-Dichlorophenyl)-2-formylphenol)
• 343603-88-3(3-(3-chlorophenyl)-2-hydroxybenzaldehyde)
• 893737-49-0(5-(3-chlorophenyl)-2-hydroxybenzaldehyde)
• 926220-49-7(5-(3,4-dichlorophenyl)-2-hydroxybenzaldehyde)
• 23602-63-3(5-Chloro-2-hydroxy-3-methylbenzaldehyde)
• 635-93-8(5-Chlorosalicylaldehyde)
• 1111129-34-0(5-(3-chloro-4-methylphenyl)-2-hydroxybenzaldehyde)
• 343604-43-3(3-(4-chlorophenyl)-2-hydroxybenzaldehyde)
• 1111121-00-6(5-(2,4-dichlorophenyl)-2-hydroxybenzaldehyde)